Sphingosine Lipid Carriers for Nucleic Acid Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nucleic acid drugs have low delivery efficiency due to inefficient delivery carriers, limiting their therapeutic effectiveness.
Innovation Solution
The use of sphingosine lipids and their derivatives as carriers to efficiently deliver small RNAs into cells, enhancing delivery efficiency and medicinal value without toxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional delivery carriers are used for nucleic acid drugs, then the drugs can be administered, but the delivery efficiency is low
Solution Approach 1:
The patent modifies the chemical structure of sphingosine lipids by changing parameters such as chain length, saturation, and functional groups to optimize delivery efficiency. Specific derivatives like C18-sphingosine and its modified forms are synthesized to enhance nucleic acid binding and cellular uptake, directly addressing the low delivery efficiency of conventional carriers
Solution Approach 2:
The patent creates composite structures where sphingosine lipid derivatives form complexes with nucleic acids. These composite materials combine the properties of lipids (membrane interaction, cellular uptake) with nucleic acids (therapeutic function), resulting in enhanced delivery efficiency and therapeutic effectiveness compared to using nucleic acids alone
2Ease of operation
If injection administration is used for nucleic acid drugs, then the drugs can be delivered, but the delivery efficiency is relatively low
Solution Approach 1:
The patent introduces sphingosine lipid derivatives as intermediary carriers between the nucleic acid drug and the cell. These lipid intermediaries facilitate the transfer of nucleic acids across cell membranes through their ability to interact with both aqueous environments and lipid membranes, significantly improving delivery efficiency while maintaining ease of administration
Data Source
AI summary
The invention provides an artificially synthesized single sphingosine lipid and use of delivering a nucleic acid thereof. More particularly, the invention provides Use or method for delivering a nucleic acid to a cell or a subject using a compound of Formula (I), a stereoisomer or a pharmaceutical acceptable salt thereof, or a combination comprising a compound of Formula (I), a stereoisomer or a pharmaceutical acceptable salt thereof,